Kezdőlap・Részvénylista・OPKO Health Inc

OPKO Health Inc

Lezárt

SzektorEgészségügy

1.6 -3.61

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1.6099999999999999

Maximum

1.72

Fő mutatók
By Trading Economics
Bevétel	46M -8.4M
Értékesítés	39M 164M
Egy részvényre jutó nyereség	-0.01
Profit margin	-5.145
Munkavállalók	2,275
EBITDA	43M 15M

Ajánlások
By TipRanks
Ajánlások	Erős vétel
12 hónapos előrejelzés	+85.74% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. okt. 28.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	295M 1.2B
Előző nyitás	5.21
Előző zárás	1.6

OPKO Health Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 20. 23:06 UTC

OPKO Health Inc shares advanced modestly in after-market trading, remaining well above its 20-day moving average and near the upper end of its one-month range.

2026. okt. 19. 23:01 UTC

OPKO Health Inc shares declined in after-market trading, continuing a downward trend as the NAHB Housing Market Index fell to 29, the lowest since June 2012.

2026. okt. 16. 23:51 UTC

OPKO Health Inc shares declined during after-market hours, falling significantly after initially showing positive returns and remaining below their 20-day moving average.

2026. okt. 15. 23:32 UTC

OPKO Health Inc's shares advanced during after-market hours on Thursday, diverging from a recent trend of higher daily closes despite currently trading lower.

2026. okt. 14. 20:07 UTC

OPKO Health Inc. is advancing during Wednesday's trading session, rebounding significantly after an initial dip amid notably positive broader market performance.

2026. okt. 13. 19:31 UTC

OPKO Health Inc shares fell sharply, currently at their lowest point of the day and well below the 20-day moving average, continuing a decline since Monday.

2026. okt. 12. 20:06 UTC

OPKO Health Inc shares are modestly lower, ending near the lower end of their one-month trading range and significantly below the 20-day moving average.

2026. okt. 9. 22:01 UTC

OPKO Health Inc declined sharply in after-market trading, moving well below its 20-day moving average and near the lower end of its one-month range.

2026. okt. 8. 20:13 UTC

OPKO Health Inc shares advanced during after-market hours.

2026. okt. 7. 20:00 UTC

OPKO Health Inc shares fell sharply, reaching their lowest point of the day and trading well below the 20-day moving average amid ongoing market weakness.

2026. okt. 6. 22:20 UTC

OPKO Health Inc saw a notable increase in after-market trading, recovering from an initial dip and marking its highest cumulative return since Tuesday's close.

2026. okt. 5. 20:06 UTC

OPKO Health Inc closed higher on Monday, showing a modest advance and peaking in late morning, while remaining around the midpoint of its one-month trading range.

2026. okt. 3. 00:01 UTC

OPKO Health Inc is trading lower in after-market hours, continuing a trend of four consecutive sessions finishing lower amid ongoing performance weakness.

2026. okt. 2. 23:41 UTC

OPKO Health Inc is trading lower in after-market hours, continuing a trend of declines following a sharp drop from its peak shortly after the market closed.

2026. okt. 1. 20:02 UTC

OPKO Health Inc shares fell sharply, trading well below its 20-day moving average and near the lower end of its one-month range.

2026. szept. 29. 20:07 UTC

OPKO Health Inc is trading modestly higher, currently around the midpoint of its one-month range and above its 20-day moving average.

2026. szept. 28. 19:46 UTC

OPKO Health Inc shares fell amid a broader market decline, remaining above the 20-day moving average and around the midpoint of its one-month range.

2026. szept. 25. 20:07 UTC

OPKO Health Inc is trading higher amid a broader market rally, which closed above its 20-day moving average despite ongoing economic concerns.

2026. szept. 24. 23:01 UTC

OPKO Health Inc is trading modestly higher in after-market hours, rebounding from three consecutive lower daily closes amid mixed performance in the health care services sector.

2026. szept. 23. 21:50 UTC

OPKO Health Inc declined in after-market trading, shifting from a positive return to a negative one since Wednesday's close, settling at the day's lowest point.

2026. szept. 22. 23:01 UTC

OPKO Health Inc is trading lower in after-market hours, declining notably from its peak, amid concerns following the unexpected drop in the Richmond Fed Manufacturing Index.

2026. szept. 21. 23:10 UTC

OPKO Health Inc's shares declined modestly in after-market trading on Monday, falling to their lowest point of the day despite remaining above the 20-day moving average.

2026. szept. 17. 20:07 UTC

OPKO Health Inc's stock is roughly flat, remaining above its 20-day moving average and near the upper end of its one-month trading range.

2026. szept. 16. 19:03 UTC

OPKO Health Inc is seeing upward movement, currently trading significantly above its 20-day moving average and near the upper end of its one-month range.

2026. szept. 15. 23:11 UTC

OPKO Health Inc shares are higher in after-market trading, advancing from a low of 1.28% to a high of 1.92% since Tuesday's close.

2026. szept. 14. 20:08 UTC

News

OPKO Health has expanded its financing with HealthCare Royalty, securing $125 million in senior secured notes linked to future royalty payments in China.

2026. szept. 11. 20:01 UTC

OPKO Health Inc shares are higher, continuing gains since Thursday's close. The stock rebounded after an early dip, with no specific news driving the movement.

2026. szept. 9. 19:16 UTC

OPKO Health Inc. shares are lower today amid broader market pressures from rising oil prices above $100 per barrel and inflation concerns.

2026. szept. 8. 23:36 UTC

No specific news was identified for OPKO Health Inc. Shares traded roughly flat after market hours, remaining near the upper end of their one-month range.

2026. szept. 4. 20:07 UTC

OPKO Health Inc. shares are higher today, rebounding significantly after an initial dip and currently 12.75% above the 20-day moving average.

Társak összehasonlítása

Árváltozás

OPKO Health Inc Előrejelzés

Célár

By TipRanks

85.74% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 3.083 USD 85.74%

Magas 4 USD

Alacsony 2.25 USD

3 Wall Street elemző 12 hónapos célárain alapulva a(z)OPKO Health Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

3 ratings

Vétel

Tartás

Eladás

3 Wall Street elemző célárain alapulva a(z)OPKO Health Inc termékhez az elmúlt 3 hónapban.

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.